Correlation Between Xilio Development and Trevi Therapeutics
Can any of the company-specific risk be diversified away by investing in both Xilio Development and Trevi Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xilio Development and Trevi Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xilio Development and Trevi Therapeutics, you can compare the effects of market volatilities on Xilio Development and Trevi Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xilio Development with a short position of Trevi Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xilio Development and Trevi Therapeutics.
Diversification Opportunities for Xilio Development and Trevi Therapeutics
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Xilio and Trevi is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Xilio Development and Trevi Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trevi Therapeutics and Xilio Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xilio Development are associated (or correlated) with Trevi Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trevi Therapeutics has no effect on the direction of Xilio Development i.e., Xilio Development and Trevi Therapeutics go up and down completely randomly.
Pair Corralation between Xilio Development and Trevi Therapeutics
Considering the 90-day investment horizon Xilio Development is expected to under-perform the Trevi Therapeutics. In addition to that, Xilio Development is 1.75 times more volatile than Trevi Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Trevi Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 219.00 in Trevi Therapeutics on September 12, 2024 and sell it today you would earn a total of 31.00 from holding Trevi Therapeutics or generate 14.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Xilio Development vs. Trevi Therapeutics
Performance |
| Timeline |
| Xilio Development |
| Trevi Therapeutics |
Xilio Development and Trevi Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Xilio Development and Trevi Therapeutics
The main advantage of trading using opposite Xilio Development and Trevi Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xilio Development position performs unexpectedly, Trevi Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trevi Therapeutics will offset losses from the drop in Trevi Therapeutics' long position.| Xilio Development vs. Connect Biopharma Holdings | Xilio Development vs. Tyra Biosciences | Xilio Development vs. RAPT Therapeutics | Xilio Development vs. Mineralys Therapeutics, Common |
| Trevi Therapeutics vs. Equillium | Trevi Therapeutics vs. DiaMedica Therapeutics | Trevi Therapeutics vs. Valneva SE ADR | Trevi Therapeutics vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |